Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>. [PDF]
Infect Drug ResistChen D +11 more
europepmc +1 more source
Clinical Outcomes of Omadacycline in Critically Ill Patients Treated for Carbapenem-Resistant Organism Infections: A Retrospective Study. [PDF]
Infect Drug ResistChen N +6 more
europepmc +1 more source
Eravacycline and omadacycline Rescue multidrug-resistant Elizabethkingia anophelis: Triple-Model evaluation across in Vitro, Galleria mellonella, and murine bacteremia systems. [PDF]
J Adv ResHu S +7 more
europepmc +1 more source
Emergence and dissemination of extensively drug-resistant ST307 <i>Klebsiella pneumoniae</i> in China. [PDF]
Microb GenomHan W +15 more
europepmc +1 more source
Novel Antibiotics and Emerging Resistance: <i>In Vitro</i> Activity of Five Antimicrobials Against Intensive Care Unit Isolates from a Turkish Tertiary Care Hospital. [PDF]
Infect Dis Clin MicrobiolKutlu HH +3 more
europepmc +1 more source
Biochemical discordance of a urinary fluoroquinolone-resistant <i>Escherichia coli</i> ST1193 as a <i>Shigella</i> species: A case report. [PDF]
IDCasesPeine B +5 more
europepmc +1 more source
Eravacycline, the First and Unique Fluorocycline Antibacterial Agent
Journal of Bacteriology and VirologyMohammad Saydur Rahman +8 more
openaire +1 more source